Public recall detail

pms-IRBESARTAN: Affected lot may contain pms-IRBESARTAN/HCTZ 150/12.5 mg tablets.

2026-08-12

medium
Health products Health product recall
Quick summary

Quick summary: pms-IRBESARTAN: Affected lot may contain pms-IRBESARTAN/HCTZ 150/12.5 mg tablets.. Reason: Health product recall. Category: Health products. Date: 2026-08-12.

Recommended action

Recommended action: compare your product with the official notice and follow the instructions published by the official source.

Recall details

Quick summary: pms-IRBESARTAN: Affected lot may contain pms-IRBESARTAN/HCTZ 150/12.5 mg tablets.. Reason: Health product recall. Category: Health products. Date: 2026-08-12.

Official details

Affected product details

Structured information extracted from the official recall notice. Confirm the identifiers and instructions in the original notice.

BrandPharmascience Inc.
Productpms-IRBESARTAN 150 mg Tablet
IssueHealth products - Contamination
Recall classType II
IdentificationRA-82479

Affected products

BrandPharmascience Inc.
Productpms-IRBESARTAN
DIN / NPN / authorizationDIN 02317079
Dosage formTablet
Strength150 mg
Lot667278

Issue

The affected lot may contain pms-IRBESARTAN/HCTZ 150/12.5 mg tablets.

What you should do

  • Verify whether your product is affected.
  • Consult your healthcare provider prior to discontinuing use of the affected product, or if you have any health concerns.
  • Contact the recalling firm if you have any questions about the recall.
  • Report any health product related side effects to Health Canada.
  • Report any other health product safety complaints to Health Canada.
Additional official information
AudienceGeneral public Healthcare Industry
CategoryHealth products - Drugs
CompaniesPharmascience Inc.6111 avenue Royalmount, suite 100, MontréalQC H4P 2T4
Recall date2026-08-10
Published byHealth Canada
Recall classType II
Alert / recall typeHealth product recall
Identification numberRA-82479
Background{}
CompaniesPharmascience Inc.6111 avenue Royalmount, suite 100, MontréalQC H4P 2T4
AudiencesGeneral public Healthcare Industry
Source updated2026-08-12

Contains information licensed under the Open Government Licence – Canada. SafetyPulse is independent of the Government of Canada.

Official source Monitor products Back to recalls

Starting...

Related recalls

Similar recalls and safety notices.

Loading related recalls...